>
Fa   |   Ar   |   En
   A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells  
   
نویسنده shin m.h. ,he y. ,marrogi e. ,piperdi s. ,ren l. ,khanna c. ,gorlick r. ,liu c. ,huang j.
منبع plos genetics - 2016 - دوره : 12 - شماره : 2
چکیده    The inactivation of p53 creates a major challenge for inducing apoptosis in cancer cells. an attractive strategy is to identify and subsequently target the survival signals in p53 defective cancer cells. here we uncover a runx2-mediated survival signal in p53 defective cancer cells. the inhibition of this signal induces apoptosis in cancer cells but not non-transformed cells. using the crispr technology,we demonstrate that p53 loss enhances the apoptosis caused by runx2 knockdown. mechanistically,runx2 provides the survival signal partially through inducing myc transcription. cancer cells have high levels of activating histone marks on the myc locus and concomitant high myc expression. runx2 knockdown decreases the levels of these histone modifications and the recruitment of the menin/mll1 (mixed lineage leukemia 1) complex to the myc locus. two inhibitors of the menin/mll1 complex induce apoptosis in p53 defective cancer cells. together,we identify a runx2-mediated epigenetic mechanism of the survival of p53 defective cancer cells and provide a proof-of-principle that the inhibition of this epigenetic axis is a promising strategy to kill p53 defective cancer cells. © 2016,public library of science.all rights reserved.
آدرس cancer and stem cell epigenetics section,laboratory of cancer biology and genetics,center for cancer research,national cancer institute,bethesda,md, United States, cancer and stem cell epigenetics section,laboratory of cancer biology and genetics,center for cancer research,national cancer institute,bethesda,md, United States, cancer and stem cell epigenetics section,laboratory of cancer biology and genetics,center for cancer research,national cancer institute,bethesda,md, United States, division of pediatric hematology-oncology,the children’s hospital at montefiore,bronx,ny, United States, pediatric oncology branch,center for cancer research,national cancer institute,bethesda,md, United States, pediatric oncology branch,center for cancer research,national cancer institute,bethesda,md, United States, division of pediatric hematology-oncology,the children’s hospital at montefiore,bronx,ny, United States, transgenic core facility,division of intramural research,national heart,lung,and blood institute,bethesda,md, United States, cancer and stem cell epigenetics section,laboratory of cancer biology and genetics,center for cancer research,national cancer institute,bethesda,md, United States
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved